Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brinavess vs Tambocor for Atrial Contractility in Atrial Fibrillation
NCT01646281Phase 4Unknown
- Sponsor
- Maastricht University Medical Center+
- Start
- Aug 2012
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vernakalant in Atrial fibrillation (AFib), sponsored by Maastricht University Medical Center+. Status: unknown.
02
Drugs
vernakalant
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01646281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01646281.